Quadrant Capital Group LLC Ptc Therapeutics, Inc. Transaction History

Quadrant Capital Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$33.53 - $54.79 $134 - $219	4 New	4 $0
Q2 2022 Aug 09, 2022	SELL	$25.6 - $45.23 $76 - $135	-3 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$33.33 - $44.6 $499 - $669	-15 Reduced 83.33%	3 $0
Q4 2021 Feb 01, 2022	SELL	$35.36 - $41.86 $3,818 - $4,520	-108 Reduced 85.71%	18 $1,000
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $3,626 - $4,384	98 Added 350.0%	126 $5,000
Q2 2021 Aug 09, 2021	SELL	$37.95 - $49.37 $1,480 - $1,925	-39 Reduced 58.21%	28 $1,000
Q1 2021 May 12, 2021	BUY	$46.8 - $68.92 $2,480 - $3,652	53 Added 378.57%	67 $3,000
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $383 - $541	8 Added 133.33%	14 $1,000
Q3 2020 Nov 13, 2020	BUY	$45.41 - $57.07 $272 - $342	6 New	6 $0
Q2 2020 Aug 13, 2020	SELL	$42.56 - $54.98 $170 - $219	-4 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $129 - $237	4 New	4 $0

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.